# CAN SLIM Progress Board

Last updated: 2026-09-14

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The theory-fidelity path now has frozen #32/#33/#34/#35 contracts, a frozen #36 execution baseline, frozen #37 sell/risk semantics, and a frozen #38 technical-deterioration evidence layer.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.**

This repository is the CAN SLIM parent/HQ. No new #33 detector/evaluator development should be added here.

Frozen production contract: `oneil-pattern-output-v2`

Production core only:

- `FLAT_BASE`
- `DOUBLE_BOTTOM`
- `CUP_WITHOUT_HANDLE`
- `CUP_WITH_HANDLE`

P6 advanced patterns (`ASCENDING_BASE`, `BASE_ON_BASE`) remain:

`DEFERRED / NOT PRODUCTION-VALIDATED / FROZEN UNTIL NEW AUTHORITATIVE MORPHOLOGY EVIDENCE EXISTS`

They must not enter downstream production-contract consumption.

## Canonical v1 state

| Area | Status |
|---|---|
| Independent CAN SLIM project | COMPLETE |
| Frozen Musaffa universe | COMPLETE / FROZEN |
| Production OHLCV / data infrastructure | COMPLETE |
| SEC/PIT fundamentals | COMPLETE / FROZEN |
| C / A | COMPLETE |
| N / S / L proxies | COMPLETE |
| I institutional sponsorship | COMPLETE / NOT PROMOTED as hard filter |
| M / SPY+QQQ ablation | COMPLETE / NOT PROMOTED |
| Historical candidates v1 | COMPLETE |
| X1-X4 / X3 | COMPLETE / PARKED |
| PORT1 / costs / robustness | COMPLETE |
| CAN SLIM quantitative v1 | RESEARCH COMPLETE |
| FWD1 | LIVE / ACCUMULATING |
| EXH2 | LIVE / PROSPECTIVE |
| Production integration | BLOCKED — FWD1 gate not met |

Historical v1 results remain frozen evidence and must not tune the theory-faithful path.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit — O'Neil vs engine v1 | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |
| 37 | Sell / risk execution semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 38 | Technical deterioration evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |

## Frozen #32/#34 staged contract

```text
BASE_RECOGNIZED
→ PIVOT_DEFINED
→ PIVOT_CROSSED
→ BREAKOUT_CONFIRMED
→ CANSLIM_ELIGIBLE
```

Missing/stale evidence remains explicit `NOT_EVALUABLE/NOT_IMPLEMENTED`.

## #34 — Theory-Faithful Candidate Generator — FROZEN

Canonical freeze record: `docs/decisions/2026-09-13-34-theory-faithful-candidate-generator-freeze.md`.

Final verification run `34758050282` → **SUCCESS**, 9 tests passed. P6 remains disabled.

## #35 — New-Candidate Validation — COMPLETE / FROZEN

Terminal verdict: `CONDITIONAL PASS / VALIDATION COMPLETE WITH UPSTREAM #33 MORPHOLOGY DEBT PRESERVED`.

Canonical historical run `34763920536`: 265,642 observations, V35-A/B/C findings = 0, frozen 60-case corpus = 20 RECOGNIZED / 20 AMBIGUOUS / 20 REJECTED.

Independent source-evidence audit run `34765922653` → **SUCCESS** with C/A/L/M 60/60 MATCH, 1,300-security historical RS cross-section, PIT violations = 0, and no future-performance fields used.

Canonical decision: `docs/decisions/2026-09-14-35-terminal-validation-decision.md`.

Upstream #33 morphology debt remains preserved. No threshold may be derived from #35 validation data.

## #36 — Execution / Entry

Canonical baseline contract: `36-execution-entry-v1`.

```text
CANSLIM_ELIGIBLE at T
→ signal known after close T
→ earliest causal execution convention T+1 open
→ fill iff pivot <= open <= pivot * 1.05
```

`T`, close T and T+1/T+3 are dataset/backtest chronology labels, not O'Neil terminology.

Semantic validation run `34785545504` → **SUCCESS**, 11 passed. R0/R1/R2/R3 integrity run `34785658367` → **SUCCESS**. Primary actionable comparison remains `BLOCKED_ON_ELIGIBLE_POPULATION` because canonical #35 contains 0 `CANSLIM_ELIGIBLE` observations. Separate BREAKOUT_CONFIRMED diagnostic run `34786603831` → **SUCCESS**, but no variant promotion is authorized.

Terminal #36 state: `BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION`.

## #37 — Sell / Risk Execution Semantics — FROZEN v1

Contract: `37-sell-risk-v1`.

Frozen boundaries include practical ~7% capital protection from actual fill, legacy 8% severity evidence, observed-open gap-through handling, +20%-25% profit-management state from pivot without mandatory full exit, exceptional-winner/eight-week context, explicit round-trip/climax limitations, and separation of market exposure from stock-level sell action.

Canonical semantic-validation run `34787905360` on commit `ff052942f2ba7bafe6fa616b3883a6ad188ff8c1` → **SUCCESS, 10 passed**.

Freeze decision: `docs/decisions/2026-09-14-37-sell-risk-v1-freeze.md`.

Terminal #37 state: `IMPLEMENTATION COMPLETE / FROZEN v1`.

## #38 — Technical Deterioration Evidence — FROZEN v1

Specification: `docs/methodology/38-technical-deterioration-evidence-spec-v1.md`.

Contract: `38-technical-deterioration-evidence-v1`.

Frozen evidence semantics:

- reproducible completed-session MA10/MA21/MA50;
- break only when completed close is strictly below the relevant MA;
- insufficient history remains `NOT_EVALUABLE`;
- `volume_ratio_50` excludes current session from the prior-50 denominator;
- heavy-volume break evidence uses the already frozen project volume boundary `>=1.40x`, explicitly classified as a quantitative evidence proxy rather than a newly asserted universal sell threshold;
- largest down-volume-since-breakout evidence is preserved descriptively;
- below-pivot evidence references pivot and loss evidence references actual fill;
- 10-week remains explicitly unimplemented pending a weekly aggregation specification; 50 daily sessions are not silently equated with 10 weeks;
- close/volume/MA evidence is known only after the completed session;
- #38 cannot itself promote a new canonical sell action.

Implementation:

- `src/canslim_research/technical_deterioration_v1.py`
- `tests/test_technical_deterioration_v1.py`
- `.github/workflows/38-technical-deterioration-v1.yml`

Canonical semantic-validation run:

- run `34788119495`
- job `103807226405`
- commit `3b7a25ead2590cf62b330420553df29cfc9d2dcf`
- **SUCCESS**
- **12 passed in 0.04s**

Freeze decision: `docs/decisions/2026-09-14-38-technical-deterioration-evidence-freeze.md`.

Terminal #38 state: `EVIDENCE LAYER COMPLETE / FROZEN v1`.

No historical-performance claim and no MA-based mandatory exit promotion is authorized.

## Data boundary

Production daily scanning may continue using the compact R2 ready snapshot (~300 bars/security). Historical validation/research may use the purpose-built full-history archive. Future bars must never alter frozen signal-T eligibility or historical entry facts.

## Forward tracks remain frozen

FWD1 boundary remains exclusive 2026-09-09 with formal review only after both >=12 completed calendar months and >=50 closed X3 portfolio trades. EXH2 remains separate and prospective. Theory-fidelity findings must not be retrofitted into either track.

## Active work from here

1. Keep #33/#34/#35/#36/#37/#38 frozen contracts unchanged.
2. Do not promote R1/R2/R3 or #38 MA/heavy-volume evidence from historical performance alone.
3. Wait for a genuine frozen `CANSLIM_ELIGIBLE` source population before primary #36/#37 performance validation.
4. The clean next theory work is a separate completed-week aggregation / 10-week evidence specification before any canonical 10-week deterioration state is claimed.
5. Round-trip action semantics, climax/exhaustion and market-exposure action remain separate future workstreams requiring explicit authoritative specifications.
6. Preserve #33 morphology debt and keep P6 advanced patterns out of production.
7. Keep FWD1/EXH2 unchanged and separate.